Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 11.00 | 0.74% | 1,488.50 | 1,486.00 | 1,486.50 | 1,491.00 | 1,476.50 | 1,478.00 | 5,748,076 | 16:35:14 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 31.38B | 2.58B | 0.6211 | 23.93 | 61.26B |
From Mar 2020 to Mar 2025
By Ian Walker
GlaxoSmithKline PLC on Friday advised holders of American Depositary Shares to reject a mini tender offer by TRC Capital Investment Corporation as the price offered falls short of their trading price.
Glaxo said it has been notified that TRC Capital has offered to buy up to 3 million ADS' for $37.10 each, in cash. It added that the price offered is a 4.5% discount to the closing price of $38.85 per ADS on May 21, the last trading day before the offer started. ADS' closed at $38.71 on Thursday.
"This mini-tender offer is at a price below the closing price for GSK's ADSs (as of the last trading day prior to the offer) and is subject to numerous conditions," Glaxo said Friday.
Write to Ian Walker at ian.walker@wsj.com
(END) Dow Jones Newswires
June 04, 2021 11:35 ET (15:35 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
1 Year Gsk Chart |
1 Month Gsk Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
